Redefining the future of Assisted Reproductive Technology (ART)

Introducing Nexpring Health: one global identity. Nine legacy IVF assisted reproductive technology (ART) brands. A single, bold vision for the future of ART.

When Astorg acquired Hamilton Thorne Research and Cook Medical’s reproductive health division, it created a moment for opportunity.

We partnered with the leadership team to define the purpose, positioning, name, and visual identity for what would become Nexpring Health and:

• Unite fragmented entities under one brand.
• Position Nexpring Health as a global MedTech leader redefining the future of ART.
• Redefine branding in the IVF sector.

The result is a brand that speaks with one voice, celebrates the precision and expertise of embryologists and clinicians, and sets a new standard in fertility innovation.

Welcome to Nexpring Health – redefining the future of ART

www.nexpringhealth.com